Skip to main content

Table 2 Identification of absorbed components and metabolites in vivo after oral administration of BHGZD by UFLC-Q-TOF-MS/MS

From: Metabolic profiling and pharmacokinetic studies of Baihu-Guizhi decoction in rats by UFLC-Q-TOF–MS/MS and UHPLC-Q-TRAP-MS/MS

No

Name

RT (min)

Formula

[M + H]+ (Error, ppm)

[M-H] (Error, ppm)

Characteristic Fragment a

POS

NEG

P1

Arginine b

1.94

C6H14N4O2

175.1187 (− 1.7)

ND

175.1176[M + H]+, 158.0911[M + H-NH2]+, 130.0952[M + H-HCOOH]+, 116.0683[M + H-NH2-CH2N2]+

ND

P2

Citric acid b

2.44

C6H8O7

ND

191.0212 (7.6)

ND

191.0211[M-H], 173.0101[M-H-H2O], 129.0196[M-H-H2O-COOH], 111.009[M-H-H2O-COOH-H2O]

P3

Isoleucine b

2.44

C6H13NO2

132.1016 (− 2.7)

ND

132.1012[M + H]+, 86.0960[M + H-HCOOH]+, 69.0697[M + H-HCOOH-NH3]+

ND

P4

Phenylalanine b

4.51

C9H11NO2

165.0789 (− 1.1)

164.0717 (5.7)

166.0847[M + H]+, 149.059[M + H-NH2]+, 120.0797[M + H-HCOOH]+, 103.0531[M + H-HCOOH-NH2]+

164.0706[M-H], 147.0433[M-H-NH2], 103.0536[M-H-COOH-NH2], 91.0522[M-H-COOH-NH2-CH]

P5

Mangiferin b

8.37

C19H18O11

423.0908 (− 3.2)

421.0779 (0.8)

423.0954[M + H]+, 369.0638[M + H-3H2O]+, 339.0489[M + H-3H2O-CH2O]+, 327.0471[M + H-C5H2O]+, 273.0394[M + H-C5H10O5]+, 257.0450[M + H-C5H10O6]+

421.0778[M-H], 403.0714[M-H-H2O], 331.0470[M-H-C3H6O3], 301.0353[M-H-C4H8O4], 259.0229[M-H-Glc], 243.0326[M-H-Glc-OH]

M5-1

Methylation of P5

10.33

C20H20O11

437.1078 (− 4.3)

435.0933 (0.5)

437.1055[M + H]+, 383.0725[M + H-3H2O]+, 341.0686[M + H-C5H2O]+, 287.0592[M + H-C5H10O5]+,

435.0935[M-H], 345.0595[M-H-C3H6O3], 315.0495[M-H-C4H8O4], 272.0374[M-H-Glc]

P6

7-O-Methyl Mangiferin b

10.33

C20H20O11

437.1060 (− 4.3)

435.0933 (0.5)

437.1055[M + H]+, 419.0939[M + H-H20]+, 317.0677[M + H-C4H8O4]+, 287.0592[M + H-C5H10O5]+

435.0935[M-H], 345.0595[M-H-C3H6O3], 315.0495[M-H-C7H6O2], 272.0374[M-H-Glc], 259.0230[M-H-Glc-CH3]

M6-1

Glucuronidation of P6

7.47

C26H28O17

ND

611.1254 (8.8)

ND

611.1301[M-H], 435.0978[M-H-GluA]

M6-2

Sulfation of P6

9.72

C20H20O14S

ND

515.0501 (1.3)

ND

515.0488[M-H]-, 435.0962[M-H-SO3]-, 345.0775[M-H-SO3-C3H6O3],

315.0520[M-H-SO3-C7H6O2]

M6-3

Methylation of P6

14.25

C21H22O11

451.1235 (− 1.6)

449.1089 (1)

451.1261[M + H]+, 275.0899[M + H-Glc]+, 257.0817[M + H-Glc-H2O]+

449.1107[M-H], 273.0769[M-H-Glc], 255.0714[M-H-Glc-H2O]

P7

Hydroxycinnamic acid

10.46

C9H8O3

165.0546 (11)

163.0454 (4.2)

165.0546[M + H]+, 147.0448[M + H-H2O]+, 119.0513[M + H-HCOOH]+, 91.0536[M + H-HCOOH-C2H2]+

163.0410[M-H], 119.0498[M-H-COOH],

93.0343[M-H-COOH-C2H2]

P8

Liquiritin apioside b

10.72

C26H30O13

568.2025 (− 2.7)

549.1782 (2.7)

568.4403[M + NH4]+,

419[M + H-C5H9O4]+,

257.0787[M + H-C5H9O4-C9H6O3]+

549.1620[M-H],

417.1096[M-H-C5H9O4],

255.0671[M-H-C5H9O4-C9H6O3]

M8-1

Glucuronidation of P8

9.74

C32H38O19

ND

725.1928

(-0.9)

ND

725.1979[M-H]-,

549.1481[M-H-GluA]

P9

Isoliquiritin b

10.88

C21H22O9

ND

417.1187

(-0.9)

ND

417.1260[M-H],

255.0641[M-H-Glc],

135.0098[M-H-Glc-C6H4O-CO]

M9-1

Glucuronidation of P9

7.92

C27H30O15

ND

593.1512

(3.3)

ND

593.1561[M-H],

417.1245[M-H-GluA],

255.0666[M-H-GluA-Glc]

M9-2

Sulfation of P9

10.78

C21H22O12S

ND

497.0759

(1.7)

ND

497.0759[M-H],

417.1193[M-H-SO3],

254.9801[M-H-SO3-Glc]

M9-3

Methylation of P9

17.69

C22H24O9

ND

431.1348

(4.3)

ND

431.1336[M-H]

P10

Ononin b

13.91

C22H22O9

431.1326

(-2.4)

ND

269.0792[M + H-Glc]+

ND

M10-1

Methylation of P10

14.11

C23H24O9

445.1493

(-5.7)

443.1348

(-1.1)

445.1391[M + H]+,

269.0970[M + H-Glc]+,

254.0726[M + H-Glc-CH3]+

443.1277[M-H],

267.0825[M-H-Glc],

252.0567[M-H-Glc-CH3]

P11

Daidzein

14.74

C15H10O4

255.0647

(− 2.1)

253.0516

(3.8)

255.0643[M + H]+,

237.0527[M + H-H2O]+,

227.0708[M + H–CO]+

253.0514[M-H],

133.0273[M-H-C7H4O2]

M11-1

Glucuronidation of P11

9.58

C21H18O10

431.0967

(− 1.3)

429.0826

(-0.2)

431.0918[M + H]+,

255.0652[M + H-Glc]+,

429.0801[M-H],

253.0508[M-H-GluA],

M11-2

Sulfation of P11

13.19

C15H10O7S

ND

333.0086

(3.5)

ND

333.0051[M-H],

253.0514[M-H-SO3]

P12

Calycosin

15.22

C16H12O5

285.074

(− 5)

ND

285.0755[M + H]+,

270.0502[M + H-CH3]+

ND

M12-1

Glucuronidation of P12

9.88

C22H20O11

461.1062

(− 3.5)

ND

461.1024[M + H]+,

285.0748[M + H-GluA]+

ND

P13

Cinnamic acid b

16.36

C9H8O2

149.0589

(− 5.6)

147.0508

(8.7)

149.0220[M + H]+,

131.0481[M + H-H2O]+,

103.0530[M + H-HCOOH]+,

77.0376[M + H-HCOOH-C2H2]+

147.0507[M-H],

103.0576[M-H-COOH],

77.0396[M-H-COOH-C2H2]

P14

Timosaponin BIII b

16.93

C45H74O18

903.4928

(− 2.2)

901.4842

(4.4)

903.4962[M + H]+,

741.4315[M + H-Glc]+,

579.3834[M + H-2Glc]+,

417.3382[M + H-2Glc-Gal]+,

399.3197[M + H-2Glc-Gal-H2O]+,

273.2187[M + H-2Glc-Gal-H2O-C8H14O]+,

255.2110[M + H-2Glc-Gal-H2O-C8H15O2]+

901.1910[M-H]

P15

3',4',7-Trihydroxyisoflavone

17.55

C15H10O5

ND

269.0469 (5.2)

ND

269.0444[M-H],

133.0306[M-H-C7H3O2-H2O]

M15-1

Glucuronidation of P15

11.57

C21H18O11

447.0907

(− 3.3)

445.0782 (1.3)

447.0908[M + H]+,

271.0608[M + H-GluA]+

445.0720[M-H],

269.0447[M-H-GluA]

P16

Formononetin b

19.85

C16H12O4

269.0808

(-− 2.9)

267.0682 (7.2)

269.0774[M + H]+

267.0667[M-H],

252.0415[M-H-CH3],

223.0446[M-H-H2O-CO]

M16-1

Glucuronidation of P16

14.14

C22H20O10

445.1129

(− 0.8)

443.0984 (3.7)

445.1095[M + H]+,

269.0806[M + H-GluA]+

443.1020[M-H],

267.0678[M-H-GluA],

252.0433[M-H-GluA-CH3]

M16-2

Sulfation of P16

18.72

C16H12O7S

ND

347.0231 (2.8)

ND

347.0258[M-H],

267.0662[M-H-SO3],

252.0447[M-H-SO3-CH3]

P17

Glycyrrhizic acid b

19.93

C42H62O16

ND

821.3997 (3.9)

ND

821.3990[M-H],

351.0582[M-H-C30H46O4]

P18

Timosaponin AIII b

25.26

C39H64O13

ND

785.4371 (5.3)

ND

785.4400[M-H],

739.4324[M-H-HCOOH],

577.3884[M-H-HCOOH-Glc]

  1. aThe losses are: Glc = glucose moiety, GluA = glucuronyl moiety, Gal = galactose moiety, ND: not detected
  2. bConfirmation in comparison with standard references